Serious Risk Linked to Type 2 Diabetes Drug Actos
January 27th, 2012 tmccoy
http://lvs-yourlawyer.s3.amazonaws.com/12-yourlawyer-ir-injuries-associated-with-the-use-of-actos.mp4
The drug Actos belongs to a newer class of type-2 diabetes drugs that increase the body’s sensitivity to insulin. Other members of this troublesome class include Rezulin and Avandia.
Actos was approved by the Federal Drug Administration in 1999; safety concerns linking use of Actos to bladder cancer started to surface ten years later. In 2011, regulators in France and Germany completely suspended sales of Actos and U.S. regulators issued a strong safety alert.
Diabetics who take Actos should see their doctors as soon as possible – especially if they have a joint diagnosis of bladder cancer or have noticed pain or frequent urination, or blood in the urine. This can be very serious.
The FDA safety alert states that Actos should never be used by diabetics who also have a past or current history of bladder cancer. The FDA’s “black label” warning states that use of Actos for more than one year is associated with an increased risk of developing bladder cancer.
To learn more about type-2 diabetes and Actos, I encourage you to watch the video above and to explore our educational website at http://yourlawyer.com. If you have legal questions, please pick up the phone and give me a call. I can answer your legal questions since this is what I do every day. I welcome your call.
